Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Exploring & developing healthcare through innovative clinical pharmacy methods
- Clinical Pharmacy 2020


It’s our great pleasure to welcome you all to for international conference on Clinical pharmacy and clinical research scheduled during Dec 11-12,2020 at Barcelona, Spain

Clinical Pharmacy 2020 could be worldwide platform for discussing, sharing and exploring new areas of studies, development and to gain knowledge on growing technologies and algorithms in the area of Clinical pharmacy and Clinical research. In Clinical Pharmacy 2020, conducts many seminars, workshops and technical sessions takes place in this allied academics with the intension to catch the attention of the experts. It would fantastically increase our knowledge in understanding the modern day requirements of the worldwide pharmaceutical industry. The professionals get an extremely good opportunity to provide many displays and lectures on distinct topics.

The conference aims to rather the researchers, principle investigators, experts and researchers working under academia and health care industries, business delegates, scientists and students across the globe to provide an international forum for the dissemination of original research results, new ideas and practical development experiences.


Welcome and warmest wishes!!

On the behalf of organizing committee, we would like to extend an invitation to join us for the 2nd International Conference on Clinical Pharmacy and Clinical Research to be held in Barcelona, Spain in Dec 11-12,2020.

Clinical Pharmacy 2020 is an international event to discuss, interact and learn more about clinical pharmacy and clinical research. It provides an interdisciplinary platform for researchers, practitioners, educators to present and discuss the most recent innovations, and educators to present and discuss the most recent trends, innovations and concerns as well as practical challenges encountered and solutions adopted in fields of clinical pharmacy


Session 1:  Bio pharmaceutics

Bio pharmaceutics is a major branch of pharmaceutical sciences which relates between the physiochemical properties of drugs in dosage form and pharmacology, toxicology, or clinical responses observed after administration. Clinical pharmacokinetics is the discipline that describes the absorption, distribution, metabolism, elimination of drugs in the patients requiring drug therapy. Clearance is the important pharmacokinetic parameter because it determines the steady state concentration for a given dose rate. The volume of distribution is a proportional constant that relates the amount of drug in the body to serum concentration. Pharmacodynamics is the quantitative study of the relation between drug exposure and pharmacologic or toxicologic responses. Pharmacodynamics interactions are where the actions of one drug are changed in presence of other Toxicokinetics  is an crucial step in clinical toxicology. The methodology is based on pharmacokinetic parameters by the exact knowledge of toxicokinetics.  It is possible to determine for each toxicon the relevant parameters which will be of use in clinical practice. The dose–response relationship, describes the change in effect on an organism caused by differing levels of exposure to an after a certain exposure time.

Session 2: Pharmaceutical Biochemistry

Pharmaceutical Biochemistry is branch of medicine which deals with the chemical reactions that occur inside the body. The medical chemist is trained in the operation and management of biochemistry laboratories and acts as authority all told elements in their use. The medical chemist governs clinical laboratories, consults, diagnoses and treat the patient with range of metabolic disorders and biomedical abnormalities. Medical biochemistry addresses the functioning of conventional and pathologic organisms from a biochemical reason of view. Through the modules in neuron degeneration, disorder and medical speciality one can expand effective understanding of consequences of biochemistry at intervals drugs abroad the evaluation and experimental skills. It principally issues with medicinal science, their uses and adverse effects on living organisms.

Session 3: Systems Pharmacology

Systems pharmacology is a multidisciplinary modelling approach that seeks to combine systems or the structures based on the networks with basic principles. These approaches have long been used in pharmacology to understand drug action at organ and organism levels. To regulate biological systems, systems biology uses computational methods for capturing molecular, cellular and tissue level interactions. The application of computational and experimental approaches of systems biology to pharmacology allow us to expand, the definition of systems pharmacology

Session 4: Pharmacoepigenetics

Pharmacoepigenetics is the study of changes in the expression of gene without change in the sequence of DNA. It provides a comprehensive volume on the role of epigenetics and epigenomics in drug discovery and development, providing a detailed, but accessible, view of the field, from basic principles, to applications in disease therapeutics. Pharmacoepigenetic  industry discuss the impact of epigenetics and epigenomics in human pathology. Biomarkers  for disease prediction, diagnosis, and treatment, current epigenetic drugs, and application of epigenetic procedures in drug development.

  •  control mechanisms for histone methylation.
  •  Psychiatric mechanisms
  •  Molecular aspects of epigenetics
  •  Pharmacy applications of epigenetics

Session 5: Therapeutic Drug Monitoring

Therapeutic Drug Monitoring is a branch of clinical pharmacology measures the concentration of a drug in the blood at regular intervals. Its main focus is on drugs with narrow therapeutic window, i.e. drugs that can easily be under-over taken. TDM is used to determine the dose at which a drug will be the most safe and effective. According to medicine, monitoring is analyses of several diseases over time. It can be performed by two ways one by continuously analysing the parameters using medicine monitor and the other by repeatedly performing the tests. Therapeutic agent that causes therapeutic effect to amount that causes toxicity is determined by therapeutic index. Medication with a small therapeutic window must be handled with care, frequently measuring the drug concentration in blood to avoid harm.

Session 6: Pharmacoeconomics

Pharmacoeconomics refers to the scientific discipline that compares the value of drug or drug therapy to another. Pharmacoeconomics analysis makes efficient allocation of limited resources among competing alternative medications and services. It includes cost minimization analysis, cost efficient analysis, cost benefit analysis, cost utility analysis. The main goal of pharmacoeconomics to improve the allocation of resources for pharmaceutical products and services and to determine which healthcare alternative provide the best healthcare outcome in terms of money spent.

Session 7: Role of Pharmacist and Research in hospital

In the health care system pharmacist play an important role by providing information about medicine. Different areas of pharmacy practice have different responsibilities the bottom line is that pharmacist help patient get well. The main aim of pharmaceutical care is to achieve positive outcomes from the use of medication which improves the patient quality of life with minimum risk. Pharmacists strive to cure disease, eliminate symptoms, reduce systems, slows a disease process, diagnose disease, and alter physiological process for the desirable result in patient health. Pharmacy practice research also called as pharmacy research, is a vital field in the area of health care, which focus on analysing how and why people access pharmacy services, how much care costs and what happens to patients as a result of this care. It aims to support evidence based policy and practice decisions where pharmacists are employed or medicines are prescribed or used.

Session 8: Adverse Drug Reactions

Adverse reactions occur as a result of drug overdose reaction, or if the person is sensitive to drug every drug has the capability for drug reactions, so hazard advantage analysis is necessary every time a drug is prescribed. ADR’s arises even after the single administration of drugs. However, long term therapies are more likely to be adverse drug reactions. At present it has become a major issue all around world and connected with financial expansion owing to hospitalization. Clinical pharmacist plays a important role in reducing the risks of ADR’s.

  •  Allergic drug reactions
  •  Dose related adverse reactions
  •  Idiosyncratic adverse reactions

Session 9: Molecular Pharmacology

Molecular Pharmacology is study of bioactive compounds at molecular level. From the knowledge of molecular biology one can determine how drugs actually work in living organisms.

  •  Introduction to Molecular pharmacology and drug targets
  •  Cell signalling, transduction and pathway analysis
  •  Application of Metabolomics to drug action
  •  Mechanism of action of novel drugs under development

Session 10: Pharmacovigilance

Pharmacovigilance is describes as the technology and activities referring to the detection, assessment, understanding and prevention of adverse effects or some other drug associated problems. Medication errors which include overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, also are of interest, even without an adverse event, because they may result in adverse drug reaction. The main aim of pharmacovigilance is to enhance the quality of patient care and patient safety in relation to use of medicine

Session 11: Endocrine Pharmacology

The Endocrine system helps to maintain internal homeostasis through the use of endogenous chemicals known as hormones. The use of drugs to help regulate and control endocrine function is an important area in pharmacology.

  •  Effects of primary hormones
  •  Alteration of endocrine function
  •  Pathways for hormonal and metabolic diseases
  •  Signal transduction mechanisms of hormones

Session 12: Neuro Pharmacology

Neuropharmacology is the study of the effects of drug at the Nervous system, with the aim of developing compounds that provide therapeutic benefit in people with psychiatric and neurological disease. Therefore, this discipline requires an in-depth knowledge of how nervous system functions as well as the way in which each drug acts upon neural circuits and alters cellular behaviour, and subsequently the organism’s behaviour. With modern insights into the molecular basis of action of many drugs, and the availability of current research methods, work is ongoing to understand how the brain works at molecular and cell levels. This includes drug delivery to the brain and understanding the role of genetic variation in drug effects between individual patients to achieve personalized treatment of nervous system illness.

  • Future Aspects of Neuropharmacology
  • Clinical Neuropharmacology
  • Neurochemical Interactions
  • Neurogensis and Repair
  • Behavioral Neuropharmacology

Session 13: Clinical Pharmacology and Toxicology

In the healthcare field, Pharmacotoxicology deals with the study of results of toxic exposure to pharmaceutical drugs and agents. Pharmacotoxicology also refers to the treatment as well as prevention of pharmaceutically induces diseases. Biotransformation is the chemical modification made by an organism on a chemical compound and additionally in mineral compounds such as CO2, NH4+, or H2O. Biotransformation is a type of chemical alteration of different chemical contents including nutrients, amino acids, toxins, and drugs inside the body. If a drug binds with unexpected proteins, receptors or enzymes that can alter different pathways other than those desired for treatment severe downstream effects can develop. Bioactivation is also considered as an important step  in the activity of certain pharmaceuticals.

  •  Toxicology testing
  •  Applied Pharmacology
  •  Toxicology and risk management
  •  Ethical and legal issues

 Session 14: Health services and policy research

Health services and policy research is an emerging field which provides scientific research, it provides the latest scientific research, reflections and overviews on current research. It aims to increase the communication among health researchers, students and educators.


The Global Clinical Pharmacy Market is aimed to reach USD 146.41 Billion from USD 113.44 Billion by 2022, at 5.2%of CGAR. 12% of Austria’s total health care is accounted by pharmaceuticals, which also explains the spending of $6 Billion per year or $550 per capita. Over the next several years 4% of annual growth rate has been expected. The pharmaceutical sales for the various regions accounts for the four main regions, namely North America with the sale percentage of 49% followed by the countries of Europe such as Turkey and Russia with the value of 21.5%. Then the followed region is Latin America with the account of 4.7% and finally the other countries Africa, Asia & Australia holds the value of 16.4%

Importance & Scope:

Clinical pharmacy is a branch of pharmacy which deals with the patient care and medication and promotes health, wellness, and disease inhibition. The pharmacist works in management with the doctors for the patient healthcare. Clinical pharmacists have wide education in the biomedical, pharmaceutical, and clinical sciences. Clinical Pharmacy consists of all the services accomplished by pharmacists practicing in hospitals, community pharmacies, nursing homes, home-based care services, clinics and any other setting wherever medicines are prescribed and used. The term clinical does not necessarily suggest an action implemented in a hospital setting. It defines that the type of activity is connected to the health of the patients. This suggests that community pharmacists and hospital pharmacists both can accomplish clinical pharmacy activities

Scope of Clinical pharmacy

. Drug information

. Drug utilization

. Adverse drug reactions and interactions

. Patient monitoring

. Disease state management

Why to attend..??

Apply new knowledge to develop, Evaluate and broadcast innovative health care delivery models. Pharmacy education models Health policy Generate and spread knowledge to advance patient care. Medication safety disease prevention and treatment Healthcare cost effectiveness and quality Pharmacy education.

Organizing Committee
OCM Member
Asif Mahmood
Clinical Research and Development
New York, USA
OCM Member
Dr. Burton M.Altura
Professor, Department of physiology, Pharmacology
SUNY Downstate Medical Center
New York, USA
OCM Member
Ayman Noreddin
Dean, Clinical Pharmacy
University of Sharjah
Dubai, United Arab Emirates

To Collaborate Scientific Professionals around the World

Conference Date December 11-12, 2020
Speaker Oppurtunity
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
General Queries
More details about

Highlights from last year's Convention

Copyright © 2020-2021 Allied Academies, All Rights Reserved.